The Qatar / Doha Market
Qatar's Pharmaceuticals & Life Sciences market — shaped by QFC financial center oversight, MOTC telecommunications regulation, and the National Cyber Security Agency's framework — is expanding rapidly on the back of World Cup infrastructure investment and Qatar's National Vision 2030 digitization program. The Personal Data Protection Law (Law No. 13 of 2016) creates data protection obligations that predate GDPR and are less widely understood.
Engineering teams deploying into Qatar need Qatar PDPL compliance, QFC regulatory requirements where applicable, and NCSA cybersecurity framework obligations mapped to the architecture. The Qatar regulatory environment rewards engineering teams that arrive with current regulatory knowledge — it is not a market where generic Gulf compliance documentation satisfies examiner scrutiny.
Compliance Coverage
Every system we deploy for Pharmaceuticals & Life Sciences in Qatar / Doha is FDA 21 CFR Part 11-compliant from architecture through deployment. FDA 21 CFR Part 11 and HIPAA compliance is enforced automatically at every commit — not assessed after the fact.
Engagement Scope
Duration: 8–16 weeks
A focused team deployed against a single Pharmaceuticals & Life Sciences platform in Qatar / Doha. FDA 21 CFR Part 11 and HIPAA-compliant architecture from day one. Fixed price, fixed output, no discovery phase.
Duration: 3–9 months
40–100 engineers running parallel workstreams across a Pharmaceuticals & Life Sciences transformation in Qatar / Doha. Multi-system compliance governance and FDA 21 CFR Part 11 and HIPAA certification maintained across the full program.
Duration: 6–18 months
100–250+ engineers owning the complete technology infrastructure for a Pharmaceuticals & Life Sciences organization in Qatar / Doha. Full FDA 21 CFR Part 11 and HIPAA compliance across every system, every integration, every deployment.